LGND
Ligand Pharmaceuticals Incorporated
$179.35
+$1.62(+0.91%)
57
Overall
40
Value
63
Tech
68
Quality
Market Cap
$3.26B
Volume
39.17K
52W Range
$93.58 - $186.40
Target Price
$184.29
EPS Estimates Overview
| Current Quarter | $1.08 | Next Quarter | $1.08 |
| Current Year | $0.31 | Next Year | $4.66 |
| QoQ Growth | +0.0% | YoY Growth | +1403.2% |
| 3Y EPS CAGR | -28.1% | Target Price | $184.29 |
| Consensus | Buy | Upside | +2.8% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LGND | $179.35 | +0.9% | 39.17K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Ligand Pharmaceuticals Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW